Ranibizumab treat and extend for neovascular age-related macular degeneration (AMD) - One-year outcomes

被引：0
|
作者：
Trivedi, Dipti [1 ]
Alfaqawi, Fadi [1 ]
Lip, Peck Lin [1 ]
Mushtaq, Bushra [1 ]
Chavan, Randhir [1 ]
机构：
[1] Birmingham & Midland Eye Ctr, Birmingham, W Midlands, England
来源：
EYE | 2018年 / 32卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
RF10
引用
收藏
页码：20 / 23
页数：4
相关论文
共 50 条
  • [41] Treatment of neovascular Age related macular degeneration (AMD) using a Modified 'Treat and Extend regimen'
    Ismail, Rehab
    Varma, Deepali
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2018, 59 (09)
  • [42] Bimonthly Ranibizumab for Neovascular Age-Related Macular Degeneration
    Cohen, Salomon Yves
    Maloberti, Bertrand
    Fajnkuchen, Franck
    Nghiem-Buffet, Sylvia
    Delahaye-Mazza, Corinne
    Grenet, Typhaine
    Quentel, Gabriel
    OPHTHALMOLOGICA, 2014, 231 (02) : 80 - 85
  • [43] Ranibizumab for neovascular age-related macular degeneration - Reply
    Rosenfeld, Philip J.
    Brown, David M.
    Schneider, Susan
    NEW ENGLAND JOURNAL OF MEDICINE, 2007, 356 (07): : 749 - 750
  • [44] Ranibizumab in neovascular age-related macular degeneration (AMD); twelve-month outcome of treat and extend regime at Wolverhampton and Midland Counties Eye Infirmary
    Parkes, Claire
    Karpoor, Meena
    Yang, Yit
    Narendran, Niro
    EYE, 2018, 32 (11) : 15 - 17
  • [45] Five-year Outcome of Aflibercept Administration with "Treat and Extend" for Neovascular Age-Related Macular Degeneration
    Wada, Iori
    Oshima, Yuji
    Fukuda, Yosuke
    Shiose, Satomi
    Kano, Kumiko
    Ishikawa, Keijiro
    Nakao, Shintaro
    Kaizu, Yoshihiro
    Hasegawa, Eiichi
    Kannan, Ram
    Ishibashi, Tatsuro
    Sonoda, Koh-Hei
    CLINICAL OPHTHALMOLOGY, 2025, 19 : 835 - 845
  • [46] A systematic review to assess the ‘treat-and-extend’ dosing regimen for neovascular age-related macular degeneration using ranibizumab
    S R Rufai
    H Almuhtaseb
    R M Paul
    B L Stuart
    T Kendrick
    H Lee
    A J Lotery
    Eye, 2017, 31 : 1337 - 1344
  • [47] Effect of posterior vitreous detachment on treat-and-extend versus monthly ranibizumab for neovascular age-related macular degeneration
    Waldstein, Sebastian M.
    Coulibaly, Leonard
    Riedl, Sophie
    Sadeghipour, Amir
    Gerendas, Bianca S.
    Schmidt-Erfurth, Ursula Margarethe
    BRITISH JOURNAL OF OPHTHALMOLOGY, 2020, 104 (07) : 899 - 903
  • [48] one plus treat and extend regimen using faricimab in patients with neovascular age-related macular degeneration
    Oishi, Akio
    Machida, Akira
    Tsuiki, Eiko
    Miyagi, Sugao
    Hirata, Yuki
    Murakami, Ryuya
    Oka, Akari
    Yoneda, Ai
    Kurihara, Junko
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2024, 65 (07)
  • [49] Mental Status and Feasibility of an Intravitreal Ranibizumab Treat-and-Extend Regimen in Patients with Neovascular Age-Related Macular Degeneration
    Aki Kato
    Tsutomu Yasukawa
    Iichiro Sugita
    Munenori Yoshida
    Miho Nozaki
    Yoshio Hirano
    Junko Kondo
    Tomohiro Abe
    Kimiko Sugita
    Takahide Okita
    Hiroshi Morita
    Noriaki Takase
    Yuichiro Ogura
    Advances in Therapy, 2022, 39 : 1403 - 1416
  • [50] A systematic review of as needed versus treat and extend ranibizumab or bevacizumab treatment regimens for neovascular age-related macular degeneration
    Chin-Yee, David
    Eck, Thomas
    Fowler, Susan
    Hardi, Angela
    Apte, Rajendra S.
    BRITISH JOURNAL OF OPHTHALMOLOGY, 2016, 100 (07) : 914 - 917
12345